Cannapharmarx Inc (CPMD) 0.6614 $CPMD CannaPhar
Post# of 273328
Posted On: 09/20/2016 9:09:01 AM
Cannapharmarx Inc (CPMD) 0.6614 $CPMD
CannaPharmaRx adds there new members to board
M2 - Thu Apr 02, 4:58AM CDT
CannaPharmaRx Inc (OTC:CPMD), a pharmaceutical company focussed on the cannabis industry, announced on Wednesday the addition of Alex Giaquinto, PhD, Elie Khalife, PhD and Steven Rule to its board of directors.
Lawsuits Involving Gary M. Cohen, CannaPharmaRx, and Golden Dragon Holding Co. Have Been Resolved and Dismissed
Marketwired - Tue Mar 31, 7:58AM CDT
CannaPharmaRx, Inc. (OTCQB: CPMD), a New Jersey-based pharmaceutical company, announced today that the lawsuit filed in Florida on October 30, 2014 against CannaPharmaRx, Gary Herick, Gerry Crocker, Jim Smeeding, Mat Sherwood and Bo Liess by former CannaPharmaRx executive Gary M. Cohen has been resolved and dismissed. The parties amicably resolved their differences before any discovery occurred or before any decision by the court on the merits of any claims. Mr. Cohen had alleged various contract and employment related claims, as well as made allegations of what he believed had been corporate fraud, misappropriation, breach of fiduciary duty, and SEC or SOX violations. CannaPharmaRx and all the individuals who had been sued categorically denied all of Mr. Cohen's claims allegations, have maintained that the allegations were false, and were prepared to assert counterclaims of their own. As part of the parties' resolution, Mr. Cohen has agreed to retract his allegations.
CannaPharmaRx's stock ticker symbol changed to 'CPMD'
M2 - Tue Mar 24, 3:59AM CDT
CannaPharmaRx Inc (OTCQB:CPMD), a pharmaceutical company, announced on Monday that the company's shares will begin trading on the OTC Bulletin Board (OTC) under its new stock ticker symbol 'CPMD', effective immediately.
CannaPharmaRx adds there new members to board
M2 - Thu Apr 02, 4:58AM CDT
CannaPharmaRx Inc (OTC:CPMD), a pharmaceutical company focussed on the cannabis industry, announced on Wednesday the addition of Alex Giaquinto, PhD, Elie Khalife, PhD and Steven Rule to its board of directors.
Lawsuits Involving Gary M. Cohen, CannaPharmaRx, and Golden Dragon Holding Co. Have Been Resolved and Dismissed
Marketwired - Tue Mar 31, 7:58AM CDT
CannaPharmaRx, Inc. (OTCQB: CPMD), a New Jersey-based pharmaceutical company, announced today that the lawsuit filed in Florida on October 30, 2014 against CannaPharmaRx, Gary Herick, Gerry Crocker, Jim Smeeding, Mat Sherwood and Bo Liess by former CannaPharmaRx executive Gary M. Cohen has been resolved and dismissed. The parties amicably resolved their differences before any discovery occurred or before any decision by the court on the merits of any claims. Mr. Cohen had alleged various contract and employment related claims, as well as made allegations of what he believed had been corporate fraud, misappropriation, breach of fiduciary duty, and SEC or SOX violations. CannaPharmaRx and all the individuals who had been sued categorically denied all of Mr. Cohen's claims allegations, have maintained that the allegations were false, and were prepared to assert counterclaims of their own. As part of the parties' resolution, Mr. Cohen has agreed to retract his allegations.
CannaPharmaRx's stock ticker symbol changed to 'CPMD'
M2 - Tue Mar 24, 3:59AM CDT
CannaPharmaRx Inc (OTCQB:CPMD), a pharmaceutical company, announced on Monday that the company's shares will begin trading on the OTC Bulletin Board (OTC) under its new stock ticker symbol 'CPMD', effective immediately.
(0)
(0)